PHIO PHARMACEUTICALS CORP. Proceeds from Other Equity
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds from Other Equity of $6.49 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2025-08-14
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for the quarter ending 2025-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for the quarter ending 2025-03-31 was $6.49M.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for the quarter ending 2024-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for the quarter ending 2024-03-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for fiscal 2023 was $7.45M.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for fiscal 2021 was $19.58M, a 61.95% increase from fiscal 2020.
- PHIO PHARMACEUTICALS CORP. proceeds from other equity for fiscal 2020 was $12.09M.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $6.49M 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $6.49M 10-Q · filed 2025-05-15 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $7.45M 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $19.58M 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $19.58M 10-Q · filed 2022-11-10 | $19.58M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $19.58M 10-Q · filed 2022-08-11 | $19.58M derived: sum of 3 quarters · filed 2022-08-11 | $19.58M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $19.58M 10-Q · filed 2022-05-12 | $19.58M derived: sum of 2 quarters · filed 2022-05-12 | $19.58M derived: sum of 3 quarters · filed 2022-05-12 | $23.10M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $3.53M derived: sum of 3 quarters · filed 2022-03-22 | $12.09M 10-K · filed 2022-03-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.53M derived: sum of 2 quarters · filed 2021-11-10 | $12.09M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $12.09M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $8.56M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |